Skip to search formSkip to main contentSkip to account menu

Dilevalol

Known as: Labetalol, (R,R)-Isomer, R,R Labetalol, R,R-Labetalol 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2000
Highly Cited
2000
OBJECTIVES The multidrug transporter P-glycoprotein (P-gp) appears to play a significant role in drug absorption and disposition… 
Review
1999
Review
1999
Essential hypertension is--at least in many subjects--associated with a decrease in insulin sensitivity, while glycaemic control… 
1991
1991
1. This study investigated the influence of age on the pharmacokinetics, pharmacodynamics, general tolerability and concentration… 
1990
1990
Cats anesthetized with alpha chloralose received saline or dilevalol (1 mg/kg, IV) during a 10‐minute infusion. Fifteen minutes… 
1988
1988
The bioavailability and pharmacokinetics of dilevalol following oral and intravenous administration were investigated in 12… 
1988
1988
Dilevalol combines a nonselective blocking action on beta-receptors with selective beta 2-agonist activity. In this double-blind… 
1988
1988
It is not surprising that there has been a search for compounds that combine two useful antihypertensive properties. The… 
1988
1988
The effects of dilevalol, a new β‐adrenergic blocking agent with β‐agonism, on renal function were determined in two groups of…